Quent Capital, LLC Roivant Sciences Ltd. Transaction History
Quent Capital, LLC
- $833 Million
- Q1 2024
A detailed history of Quent Capital, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Quent Capital, LLC holds 158 shares of ROIV stock, worth $1,655. This represents 0.0% of its overall portfolio holdings.
Number of Shares
158
Previous 158
-0.0%
Holding current value
$1,655
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ROIV
# of Institutions
263Shares Held
489MCall Options Held
565KPut Options Held
1.68M-
Sb Investment Advisers (Uk) LTD London, X073MShares$765 Million7.6% of portfolio
-
Viking Global Investors LP69.4MShares$727 Million2.78% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$699 Million65.04% of portfolio
-
Black Rock Inc. New York, NY36.2MShares$379 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.6MShares$373 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $7.38B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...